Susquehanna Fundamental Investments, LLC Novavax Inc Transaction History
Susquehanna Fundamental Investments, LLC
- $4.33 Trillion
- Q2 2024
A detailed history of Susquehanna Fundamental Investments, LLC transactions in Novavax Inc stock. As of the latest transaction made, Susquehanna Fundamental Investments, LLC holds 343,414 shares of NVAX stock, worth $2.94 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
343,414
Previous 313,580
9.51%
Holding current value
$2.94 Million
Previous $1.5 Billion
190.05%
% of portfolio
0.1%
Previous 0.07%
Shares
4 transactions
Others Institutions Holding NVAX
# of Institutions
290Shares Held
93.4MCall Options Held
6.95MPut Options Held
9.4M-
Vanguard Group Inc Valley Forge, PA15.4MShares$132 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$102 Million0.0% of portfolio
-
Shah Capital Management9.82MShares$84.1 Million40.63% of portfolio
-
State Street Corp Boston, MA7.69MShares$65.9 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY5.94MShares$50.9 Million0.07% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $670M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...